| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |